A former practising physician named the number one pharmaceuticals analyst in Thomson Reuters Extel rankings four years running has quit Morgan Stanley for Citigroup, in a swoop headhunters say could have netted him up to £1m in annual pay.
Citi announced this morning that it had hired Dr. Andrew Baum as head of pharmaceuticals and healthcare research for Europe. He will be based in London and report to Terrence Sinclair, head of equity research for Europe.
